Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Stress may be the reason people with obesity are more likely to get other metabolic diseases, such as type 2 diabetes, ...

Furthermore, we are excited to advance our obesity programs and start multiple clinical trials ... can be found at via the identifier NCT06565611 Presented a poster titled "Structural Modification ...

Presented New CRB-913 Pre-Clinical Data at Obesity Week 2024 - Phase 1 Trial Expected to Commence in Q1 2025 ...

Weight loss can be a tricky journey, so diet experts have pinpointed a number of high-protein foods that can help you to ...

Greater use of obesity drugs and other pricey medicines helped spur Cardinal Health to a fiscal first-quarter earnings beat, boosting its share price as well as competing drug distributors.

due to big misses in sales of anti-obesity drugs Mounjaro and Zepbound. The company said sales of Mounjaro and Zepbound were hurt in the latest quarter by wholesalers cutting inventory ...

Eli Lilly shares slid after the drugmaker reported disappointing quarterly results, with sales of its popular diabetes and anti-obesity drugs lower than expected. Lilly said inventory decreases by ...

The company's stock outlook is increasingly tied to the success of its obesity drug program, particularly MariTide, while its diverse pipeline and established products continue to shape its market ...